<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vestim</journal-id><journal-title-group><journal-title xml:lang="ru">Известия Национальной  академии наук Беларуси. Серия медицинских наук</journal-title><trans-title-group xml:lang="en"><trans-title>Proceedings of the National Academy of Sciences of Belarus, Medical series</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1814-6023</issn><issn pub-type="epub">2524-2350</issn><publisher><publisher-name>The Republican Unitary Enterprise Publishing House "Belaruskaya Navuka"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29235/1814-6023-2022-19-4-351-363</article-id><article-id custom-type="elpub" pub-id-type="custom">vestim-874</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ И ЭКСПЕРИМЕНТАЛЬНАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL AND EXPERIMENTAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Гендерные особенности электрокардиограммы у пациентов с лекарственно-индуцированным синдромом удлиненного интервала QT на фоне антиаритмической терапии</article-title><trans-title-group xml:lang="en"><trans-title>Gender electrocardiographic features in patients with drug-induced long QT syndrome caused by antiarrhythmic therapy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5211-709X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колоцей</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kalatsei</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колоцей Людмила Владимировна – аспирант, ассистент.</p><p>ул. Горького, 80, 230009, Гродно</p></bio><bio xml:lang="en"><p>Liudmila V. Kalatsei – Postgraduate student, Assistant, Grodno State Medical University.</p><p>80, Gorky Str., 230009, Grodno</p></bio><email xlink:type="simple">lkolotsey@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1706-1243</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Снежицкий</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Snezhitskiy</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Снежицкий Виктор Александрович – член-корреспондент, доктор медицинских наук, профессор.</p><p>ул. Горького, 80, 230009, Гродно</p></bio><bio xml:lang="en"><p>Viktor A. Snezhitskiy – Corresponding Member, D. Sc. (Med.), Professor, Grodno State Medical University.</p><p>80, Gorky Str., 230009, Grodno</p></bio><email xlink:type="simple">vsnezh@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Гродненский государственный медицинский университет</institution></aff><aff xml:lang="en"><institution>Grodno State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>28</day><month>11</month><year>2022</year></pub-date><volume>19</volume><issue>4</issue><fpage>351</fpage><lpage>363</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Колоцей Л.В., Снежицкий В.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Колоцей Л.В., Снежицкий В.А.</copyright-holder><copyright-holder xml:lang="en">Kalatsei L.V., Snezhitskiy V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vestimed.belnauka.by/jour/article/view/874">https://vestimed.belnauka.by/jour/article/view/874</self-uri><abstract><p>Женский пол традиционно относится к числу факторов риска удлинения интервала QT и развития полиморфной желудочковой тахикардии (ЖТ) типа «пируэт». Однако, несмотря на большое количество исследований, посвященных электрокардиографическим особенностям у пациентов с врожденным синдромом удлиненного интервала QT, имеется сравнительно немного информации о гендерных различиях показателей элекрокардиограмм (ЭКГ) на фоне лекарственно-индуцированного удлинения интервала QT.</p><p>Цель настоящего исследования ‒ оценка гендерных особенностей электрокардиографических показателей, характеризующих деполяризацию и реполяризацию миокарда, у пациентов с лекарственно-индуцированным удлинением интервала QT на фоне приема антиаритмических препаратов III класса.</p><p>Для достижения поставленной цели было обследовано 67 пациентов с лекарственно-индуцированным удлинением интервала QT на фоне  приема  антиаритмических препаратов  III класса  (амиодарон  либо  соталол),  из  них 38 (56,8 %) женщин и 29 (43,2 %) мужчин, средний возраст – 57,1 ± 9,5 года. Всем пациентам проводились клинико-лабораторные и неинвазивные электрофизиологические исследования, включавшие в себя запись ЭКГ в 12 отведениях и 24-часовое холтеровское мониторирование ЭКГ (ХМ-ЭКГ).</p><p>Пациенты исследуемых групп были сопоставимы по возрасту и клинико-нозологической характеристике, однако более  высокая  распространенность  фибрилляции  предсердий  отмечалась  у  мужчин  (82,7  %  против  52,6  %, p = 0,03). Общая продолжительность приема антиаритмических препаратов III класса у пациентов мужского пола составила 3,79 ± 1,49 сут, что значимо отличалось от аналогичного показателя у пациенток женского пола (3,11 ± 1,15 сут, p = 0,044). При анализе исходных показателей стандартных ЭКГ пациентов, записанных до начала приема антиаритмических препаратов, между группами не выявлено статистически достоверных различий, за исключением больших значений корригированного индекса кардиоэлектрофизиологического баланса (QTc/QRS)  у пациенток женского пола ( p = 0,037). На фоне приема антиаритмических препаратов III класса у женщин отмечались более высокая продолжительность интервалов QTс  ( p = 0,03) и JTс ( p = 0,023), а также дисперсия интервалов QT ( p = 0,012)  и JT ( p = 0,006). По данным ХМ-ЭКГ, у пациенток женского пола наблюдалась тенденция к повышенному риску развития неустойчивой полиморфной ЖТ ( p = 0,105).</p><p>Полученные результаты свидетельствуют о сложном взаимодействии между полом и реполяризацией, которое требует дальнейшего исследования. Учитывая роль гендерных особенностей в процессе реполяризации миокарда, следует соблюдать осторожность не только при назначении антиаритмических препаратов III класса женщинам, но   и принимать во внимание вопросы гендерной специфичности на этапе доклинической и клинической разработки лекарственных препаратов, обладающих эффектом удлинения интервала QT.</p></abstract><trans-abstract xml:lang="en"><p>Female gender is traditionally considered to be a risk factor for the QT interval prolongation and polymorphic ventricular tachycardia «torsades de pointes». However, despite a large number of studies on electrocardiographic features in patients with congenital long QT interval syndrome, there is relatively little information on gender ECG differences in the drug-induced QT interval prolongation.</p><p>The aim of this study is to evaluate the gender characteristics of electrocardiographic parameters characterizing myocardial depolarization and repolarization in patients with drug-induced QT interval prolongation induced by class III antiarrhythmic drugs.</p><p>67 patients with drug-induced QT interval prolongation induced class III antiarrhythmic drugs (amiodarone or sotalol) were examined, of which 38 (56.8 %) women and 29 (43.2 %) men, mean age – 57.1 ± 9.5 years. All patients underwent clinical laboratory and non-invasive electrophysiological studies, which included 12-lead ECG recording and 24-hour Holter monitoring. The patients of both genders were comparable in age and clinical characteristics, with the exception of a higher prevalence of AF in men (82.7 % vs 52.6 %, p = 0.03). The total duration of taking class III antiarrhythmic drugs in male patients was 3.79 ± 1.49 days, which significantly differed from female patients (3.11 ± 1.15 days, p = 0.044). When analyzing the initial standard ECG of patients recorded before starting antiarrhythmic drugs, there were no statistically significant differences between the groups, with the exception of large values of the corrected cardioelectrophysiological balance index (QTc/QRS) in female patients ( p = 0.037). While taking class III antiarrhythmic drugs, women had a higher duration of QTc ( p = 0.03) and JTc ( p = 0.023) intervals, as well as a dispersion of QT ( p = 0.012) and JT ( p = 0.006) intervals. According to Holter monitoring data, female patients were more likely to have an increased risk of developing non-sustained polymorphic VT ( p = 0.105).</p><p>These results suggest a complex interplay between gender and repolarization that needs further investigation. Considering the gender characteristics of the process of myocardial repolarization, it should be taken into account not only when prescribing class III antiarrhythmic drugs to women, but also during preclinical and clinical development of drugs that have the QT interval prolonging effect.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>интервал QT</kwd><kwd>лекарственно-индуцированный синдром удлиненного интервала QT</kwd><kwd>антиаритмические препараты</kwd><kwd>неустойчивая полиморфная желудочковая тахикардия</kwd><kwd>электрокардиография</kwd><kwd>реполяризация</kwd><kwd>дисперсия интервала QT</kwd><kwd>корригированный индекс кардиоэлектрофизиологического баланса</kwd></kwd-group><kwd-group xml:lang="en"><kwd>QT interval</kwd><kwd>drug-induced long QT syndrome</kwd><kwd>antiarrhythmic drugs</kwd><kwd>non-sustained polymorphic ventricular tachycardia</kwd><kwd>electrocardiography</kwd><kwd>repolarization</kwd><kwd>QT interval dispersion</kwd><kwd>corrected index of cardioelectrophysiological balance</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bazett, H. C. An analysis of the time-relations of electrocardiograms / H. C. Bazett // Ann. Noninvasive Electrocardiol. ‒ 1997. – Vol. 2, N 2. – P. 177–194. https://doi.org/10.1111/j.1542-474X.1997.tb00325.x</mixed-citation><mixed-citation xml:lang="en">Bazett H. C. An analysis of the time-relations of electrocardiograms. Annals of Noninvasive Electrocardiology, 1997, vol. 2, no. 2, pp. 177–194. https://doi.org/10.1111/j.1542-474X.1997.tb00325.x</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Moss, A. J. Gender differences in ECG parameters and their clinical implications / A. J. Moss // Ann. Noninvasive Electrocardiol. ‒ 2010. – Vol. 15, N 1. – P. 1–2. https://doi.org/10.1111/j.1542-474X.2009.00345.x</mixed-citation><mixed-citation xml:lang="en">Moss A. J. Gender differences in ECG parameters and their clinical implications. Annals of Noninvasive Electrocardiology, 2010, vol. 15 (1), pp. 1‒2. https://doi.org/10.1111/j.1542-474X.2009.00345.x</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society / C. Linde [et al.] // Europace. – 2018. – Vol. 20, N 10. – P. 1565–1565ao. https://doi.org/10.1093/europace/euy067.</mixed-citation><mixed-citation xml:lang="en">Linde C., Bongiorni M. G., Birgersdotter-Green U., Curtis A. B., Deisenhofer I., Furokawa T. [et al.]. Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society. Europace, 2018, vol. 20, no. 10, pp. 1565‒1565ao. https://doi.org/10.1093/europace/euy067</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sex and race differences in QRS duration / K. Hnatkova [et al.] // Europace. ‒ 2016. – Vol. 18, N 12. – P. 1842–1849. https://doi.org/10.1093/europace/euw065</mixed-citation><mixed-citation xml:lang="en">Hnatkova K., Smetana P., Toman O., Schmidt G., Malik M. Sex and race differences in QRS duration. Europace, 2016, vol. 18, no. 12, pp. 1842‒1849. https://doi.org/10.1093/europace/euw065</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Physiologic heart rate dependency 10.1093/europace/euw065 of the PQ interval and its sex differences / O. Toman [et al.] // Sci. Rep. ‒ 2020. – Vol. 10, N 1. – Art. 2551. https://doi.org/10.1038/s41598-020-59480-8</mixed-citation><mixed-citation xml:lang="en">Toman O., Hnatkova K., Smetana P., Huster K. M., Šišáková M., Barthel P., Novotný T., Schmidt G., Malik M. Physiologic heart rate dependency of the PQ interval and its sex differences. Scientific Reports, 2020, vol. 10, no. 1, art. 2551. https://doi.org/10.1038/s41598-020-59480-8</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Macfarlane, P. W. The Influence of Age and Sex on the Electrocardiogram / P. W. Macfarlane // Sex-Specific Analysis of Cardiovascular Function / eds. : P. L. M. Kerkhof, V. M. Miller. ‒ Cham, 2018. – P. 93–106.</mixed-citation><mixed-citation xml:lang="en">Macfarlane P. W. The Influence of Age and Sex on the Electrocardiogram. Sex-Specific Analysis of Cardiovascular Function. Cham, 2018, pp. 93‒106.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Salama, G. Sex differences in the mechanisms underlying long QT syndrome / G. Salama, G. C. Bett // Am. J. Physiol. Heart Circ. Physiol. ‒ 2014. – Vol. 307, N 5. – P. H640–H648. https://doi.org/10.1152/ajpheart.00864.2013</mixed-citation><mixed-citation xml:lang="en">Salama G., Bett G. C. Sex differences in the mechanisms underlying long QT syndrome. American Journal of Physiology-Heart and Circulatory Physiology, 2014, vol. 307, no. 5, pp. H640‒H648. https://doi.org/10.1152/ajpheart.00864.2013</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Колоцей, Л. В. Методологические подходы к измерению и оценке длительности интервала QT стандартной электрокардиограммы / Л. В. Колоцей, В. А. Снежицкий // Журн. Гродн. гос. мед. ун-та. – 2019. – Т. 17, № 1. – С. 99–105.</mixed-citation><mixed-citation xml:lang="en">Kolotsei L. V., Snezhitskii V. A. Methodological approaches to measuring and estimating the duration of QT interval of a standard electrocardiogram. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta [Journal of the Grodno State Medical University], 2019, vol. 17, no. 1, pp. 99‒105 (Russian).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mechanisms of sex and age differences in ventricular repolarization in humans / J. Vicente [et al.] // Am. Heart J. ‒ 2014. – Vol. 168, N 5. – P. 749–756. https://doi.org/10.1016/j.ahj.2014.07.010</mixed-citation><mixed-citation xml:lang="en">Vicente J., Johannesen L., Galeotti L., Strauss D. G. Mechanisms of sex and age differences in ventricular repolarization in humans. American Heart Journal, 2014, vol. 168, no. 5, pp. 749‒756. https://doi.org/10.1016/j.ahj.2014.07.010</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Influence of steroid hormones on ventricular repolarization / J. E. Salem [et al.] // Pharmacol. Ther. – 2016. – Vol. 167. – P. 38–47. https://doi.org/10.1016/j.pharmthera.2016.07.005</mixed-citation><mixed-citation xml:lang="en">Salem J. E., Alexandre J., Bachelot A., Funck-Brentano C. Influence of steroid hormones on ventricular repolarization. Pharmacology and Therapeutics, 2016, vol. 167, pp. 38‒47. https://doi.org/10.1016/j.pharmthera.2016.07.005</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Coker, S. J. Drugs for men and women – how important is gender as a risk factor for TdP? / S. J. Coker // Pharmacol. Ther. ‒ 2008. – Vol. 119, N 2. – P. 186–194. https://doi.org/10.1016/j.pharmthera.2008.03.005</mixed-citation><mixed-citation xml:lang="en">Coker S. J. Drugs for men and women – how important is gender as a risk factor for TdP? Pharmacology and Therapeutics, 2008, vol. 119, no. 2, pp. 186‒194. https://doi.org/10.1016/j.pharmthera.2008.03.005</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol / B. Darpo [et al.] // Br. J. Clin. Pharmacol. ‒ 2014. – Vol. 77, N 3. – P. 522–531. https://doi.org/10.1111/bcp.12201</mixed-citation><mixed-citation xml:lang="en">Darpo B., Karnad D. R., Badilini F., Florian J., Garnett C. E., Kothari S., Panicker G. K., Sarapa N. Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol. British Journal of Clinical Pharmacology, 2014, vol. 77, no. 3, pp. 522‒531. https://doi.org/10.1111/bcp.12201</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">A new biomarker-index of cardiac electrophysiological balance (iCEB)–plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs) / H. R. Lu [et al.] // J. Pharmacol. Toxicol. Methods. – 2013. – Vol. 68, N 2. – P. 250–259. https://doi.org/10.1016/j.vascn.2013.01.003</mixed-citation><mixed-citation xml:lang="en">Lu H. R., Yan G. X., Gallacher D. J. A new biomarker-index of cardiac electrophysiological balance (iCEB) – plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs). Journal of Pharmacological and Toxicological Methods, 2013, vol. 68, no. 2, pp. 250‒259. https://doi.org/10.1016/j.vascn.2013.01.003</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Evaluation of Index of Cardio-Electrophysiological Balance (iCEB) as a New Biomarker for the Identification of Patients at Increased Arrhythmic Risk / T. Robyns [et al.] // Ann. Noninvasive Electrocardiol. – 2016. – Vol. 21, N 3. – P. 294–304. https://doi.org/10.1111/anec.12309</mixed-citation><mixed-citation xml:lang="en">Robyns T., Lu H. R., Gallacher D. J., Garweg C., Ector J., Willems R., Janssens S., Nuyens D. Evaluation of Index of Cardio-Electrophysiological Balance (iCEB) as a New Biomarker for the Identification of Patients at Increased Arrhythmic Risk. Annals of Noninvasive Electrocardiology, 2016, vol. 21, no. 3, pp. 294‒304. https://doi.org/10.1111/anec.12309</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">CredibleMeds [Electronic resource]. – Mode of access: https://crediblemeds.org. – Date of access: 20.02.2022.</mixed-citation><mixed-citation xml:lang="en">CredibleMeds [Electronic resource]. Available at: https://crediblemeds.org (accessed 20.02.2022).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Age and sex estimation using artificial intelligence from standard 12-lead ECGs / Z. I. Attia [et al.] // Circ. Arrhythm. Electrophysiol. – 2019. – Vol. 12, N 9. – P. e007284. https://doi.org/10.1161/CIRCEP.119.007284</mixed-citation><mixed-citation xml:lang="en">Attia Z. I., Friedman P. A., Noseworthy P. A., Lopez-Jimenez F., Ladewig D. J., Satam G. [et al.]. Age and sex estimation using artificial intelligence from standard 12-lead ECGs. Circulation: Arrhythmia and Electrophysiology, 2019, vol. 12, no. 9, p. e007284. https://doi.org/10.1161/CIRCEP.119.007284</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Gender differences in the long QT syndrome: effects of beta-adrenoceptor blockade / C. E. Conrath [et al.] // Cardiovasc. Res. – 2002. – Vol. 53, N 3. – P. 770–776. https://doi.org/10.1016/s0008-6363(01)00477-1</mixed-citation><mixed-citation xml:lang="en">Conrath C. E., Wilde A. A., Jongbloed R. J., Alders M., van Langen I. M., van Tintelen J. P., Doevendans P. A., Opthof T. Gender differences in the long QT syndrome: effects of beta-adrenoceptor blockade. Cardiovascular Research, 2002, vol. 53, no. 3, pp. 770‒776. https://doi.org/10.1016/s0008-6363(01)00477-1</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Larger dispersion of Ina in female dog ventricle as a mechanism for gender-specific incidence of cardiac arrhythmias / H. Barajas-Martinez [et al.] // Cardiovasc. Res. – 2009. – Vol. 81, N 1. – P. 82–89. https://doi.org/10.1093/cvr/cvn255</mixed-citation><mixed-citation xml:lang="en">Barajas-Martinez H., Haufe V., Chamberland C., Roy M.-J. B., Fecteau M. H., Cordeiro J. M., Dumaine R. Larger dispersion of Ina in female dog ventricle as a mechanism for gender-specific incidence of cardiac arrhythmias. Cardiovascular Research, 2009, vol. 81, no. 1, pp. 82‒89. https://doi.org/10.1093/cvr/cvn255</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Sex-specific IKAS activation in rabbit ventricles with drug-induced QT prolongation / A. Z. Vu [et al.] // Heart Rhythm. – 2021. – Vol. 18, N 1. – P. 88–97. https://doi.org/10.1016/j.hrthm.2020.07.020</mixed-citation><mixed-citation xml:lang="en">Wu A. Z., Chen M., Yin D., Everett T. H., Chen Z., Rubart M., Weiss J. N., Qu Z., Chen P.-S. Sex-specific IKAS activation in rabbit ventricles with drug-induced QT prolongation. Heart Rhythm, 2021, vol. 18, no. 1, pp. 88‒97. https://doi.org/10.1016/j.hrthm.2020.07.020</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Sex differences in repolarization and slow delayed rectifier potassium current and their regulation by sympathetic stimulation in rabbits / Y. Zhu [et al.] // Pflugers Archiv. – 2013. – Vol. 465, N 6. – P. 805–818. https://doi.org/10.1007/s00424-012-1193-9</mixed-citation><mixed-citation xml:lang="en">Zhu Y., Ai X., Oster R. A., Bers D. M., Pogwizd S. M. Sex differences in repolarization and slow delayed rectifier potassium current and their regulation by sympathetic stimulation in rabbits. Pflügers Archiv, 2013, vol. 465, no. 6, pp. 805‒818. https://doi.org/10.1007/s00424-012-1193-9</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs / R. R. Makkar [et al.] // JAMA. – 1993. – Vol. 270, N 21. – P. 2590–2597. https://doi.org/10.1001/jama.270.21.2590</mixed-citation><mixed-citation xml:lang="en">Makkar R. R., Fromm B. S., Steinman R. T., Meissner M. D., Lehmann M. H. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA, 1993, vol. 270, no. 21, pp. 2590‒2597. https://doi.org/10.1001/jama.270.21.2590</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sex difference in risk of torsade de pointes with d,l-sotalol / M. H. Lehmann [et al.] // Circulation. – 1996. – Vol. 94, N 10. – P. 2535–2541. https://doi.org/10.1161/01.cir.94.10.2535</mixed-citation><mixed-citation xml:lang="en">Lehmann M. H., Hardy S., Archibald D., Quart B., MacNeil D. J. Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation, 1996, vol. 94, no. 10, pp. 2535‒2541. https://doi.org/10.1161/01.cir.94.10.2535</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Cardiac actions of erythromycin: influence of female sex / M. D. Drici [et al.] // JAMA. – 1998. – Vol. 280, N 20. – P. 1774–1776. https://doi.org/10.1001/jama.280.20.1774</mixed-citation><mixed-citation xml:lang="en">Drici M. D., Knollmann B. C., Wang W. X., Woosley R. L. Cardiac actions of erythromycin: influence of female sex. JAMA, 1998, vol. 280, no. 20, pp. 1774‒1776. https://doi.org/10.1001/jama.280.20.1774</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Mechanism of cardiotoxicity of halofantrine / D. L. Wesche [et al.] // Clin. Pharmacol. Ther. – 2000. – Vol. 67, N 5. – P. 521–529. https://doi.org/10.1067/mcp.2000.106127</mixed-citation><mixed-citation xml:lang="en">Wesche D. L., Schuster B. G., Wang W. X., Woosley R. L. Mechanism of cardiotoxicity of halofantrine. Clinical Pharmacology and Therapeutics, 2000, vol. 67, no. 5, pp. 521‒529. https://doi.org/10.1067/mcp.2000.106127</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Nachimuthu, S. Drug-induced QT interval prolongation: mechanisms and clinical management. / S. Nachimuthu, M. D. Assar, J. M. Schussler // Ther. Adv. Drug Saf. – 2012. – Vol. 3, N 5. – P. 241–253. https://doi.org/10.1177/2042098612454283</mixed-citation><mixed-citation xml:lang="en">Nachimuthu S., Assar M. D., Schussler J. M. Drug-induced QT interval prolongation: mechanisms and clinical management. Therapeutic Advances in Drug Safety, 2012, vol. 3, no. 5, pp. 241‒253. https://doi.org/10.1177/2042098612454283</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
